LitAlert ~~

    • Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer.
    • Du F, Wang W, Wang Y, Li M, Zhu A, Wang J, Cai R, Ma F, Fan Y, Li Q, Zhang P, Todorovic V, Yuan P, Xu B.
    • Breast Cancer Res Treat. 2020 May 11. doi: 10.1007/s10549-020-05648-9. [Epub ahead of print]
    • Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer.
    • Bouberhan S, Philp L, Hill S, Al-Alem LF, Bo Rueda B.
    • Cancers (Basel). 2020 May 11;12(5). pii: E1206. doi: 10.3390/cancers12051206.